
As the global population ages, chronic kidney disease (CKD) prevalence among older individuals is expected to rise, challenging healthcare systems. Treatment for older CKD patients should align with general population strategies, focusing on reducing cardiovascular events and slowing disease progression. Emerging therapies like SGLT-2 inhibitors and GLP-1 receptor agonists show promise. At the same time, non-pharmacological interventions, including nutrition and exercise, are crucial for enhancing pharmacotherapy effects and maintaining cognitive function and quality of life. Kidney replacement therapy decisions must consider factors beyond age with personalized, patient-centered approaches. Digital technologies offer potential transformations in managing CKD in the aging population.
Like
Save
Share